Skip to main content

Table 2 A comparison of Growth and Clinical Outcomes between Infants Exposed to and Not Exposed to HIV in the 1st nine months of life

From: Growth patterns and clinical outcomes in association with breastfeeding duration in HIV exposed and unexposed infants: a cohort study in KwaZulu Natal, South Africa

Infant Growth and Clinical Outcomes

Infants Exposed to HIV

Infants Not Exposed to HIV

P Value

Infant Growth, WHO Z scores (median [IQR])

Age 3 months

n = 123

n = 107

 

 WAZ

0.27 (− 0.41; 0.88)

0.03 (− 0.69; 1.03)

0.360

 LAZ

0.91 (− 0.24; 1.72)

− 1.63 (− 3.60; − 0.31)

< 0.001

 WLZ

− 0.19 (− 1.26; 0.76)

2.09 (0.16; 3.79)

< 0.001

Age 6 months

n = 123

n = 67

 

 WAZ

0.31 (− 0.38; 0.85)

0.54 (− 0.40; 1.25)

0.115

 LAZ

0.51 (− 0.48; 1.47)

− 0.37 (− 1.59; 0.99)

0.001

 WLZ

0.17 (− 0.81; 0.79)

0.92 (0.28; 2.15)

< 0.001

Age 9 months

n = 123

n = 49

 

 WAZ

0.41 (−0.39; 0.97)

0.85 (− 0.03; 1.82)

0.007

 LAZ

0.77 (− 0.22; 1.93)

0.13 (− 0.58; 1.37)

0.077

 WLZ

0.05 (−0.67; 0.71)

0.97 (− 0.21; 2.15)

< 0.001

Growth Faltering n (%)

Age 3 months

 Underweight

2 (1.6)

9 (8.18)

0.026

 Stunting

5 (3.96)

48 (44.9)

< 0.001

 Wasting

11 (8.73)

6 (5.61)

0.452

Age 6 months

 Underweight

4 (3.23)

1 (1.49)

0.659

 Stunting

6 (4.84)

14 (20.9)

< 0.001

 Wasting

9 (7.26)

3 (4.48)

0.545

Age 9 months

 Underweight

1 (0.82)

0

1.000

 Stunting

7 (5.74)

1 (2.0)

0.440

 Wasting

2 (1.64)

2 (4.0)

0.581

Infants with 1 or more episodes n(%)

 Rash/Skin Disease

59 (44.4)

20 (12.8)

< 0.0001

 Fever

1 (0.8)

6 (3.9)

0.129

 URTI

40 (30.1)

17 (10.9)

< 0.0001

 Acute GE

7 (5.3)

5 (3.2)

0.395

 LRTI

4 (3.0)

4 (2.6)

1.000